AirSculpt Technologies, Inc. (AIRS)

Market Cap	327.96M
Revenue (ttm)	195.92M
Net Income (ttm)	-4.48M
Shares Out	57.54M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	44.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,716
Open	5.38
Previous Close	5.44
Day's Range	5.36 - 5.74
52-Week Range	4.49 - 9.94
Beta	1.82
Analysts	Buy
Price Target	8.00 (+40.35%)
Earnings Date	May 10, 2024

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool....

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 381
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS

Financial Performance

In 2023, AIRS's revenue was $195.92 million, an increase of 16.07% compared to the previous year's $168.79 million. Losses were -$4.48 million, -69.49% less than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for AIRS stock is "Buy." The 12-month stock price forecast is $8.0, which is an increase of 40.35% from the latest price.

Price Target

$8.0

(40.35% upside)

Analyst Consensus: Buy